The history of Sildenafil presents a complex picture for investors. While the initial release generated substantial gains, the lapse of its intellectual property protection opened the floodgates to generic competitors, https://bookmarkspecial.com/story21819519/sildenafil-and-the-pharmaceutical-industry-a-risky-bet